Aerospace firm Boeing was looking to sell its space business, which is part of its Defense, Space & Security segment, The ...

Teva receives a buy rating due to growth potential as a global generic drugmaker, despite high debt and legal/regulatory ...

The company focuses on creating generic versions of controlled-release ... Elite Pharmaceuticals has maintained a strong balance sheet. Working capital has doubled, and equity has increased ...

Remember that financial advisor is a generic term with no legal definition ... flow planning — analyzing a client’s income and balance sheet — and tax and estate planning, including ...

Analysts dive into balance sheets and income statements to estimate ... medical test taking was going to be permanent. Meanwhile, generic drugmaker Perrigo’s newer CEO is making better capital ...

Progressive devotes one page to a generic discussion of risks (page ... Moreover, the assets side of all these insurers’ balance sheets is exposed to climate risks. Nationwide puts out a 15 ...

In a report released today, Glen Santangelo from Jefferies assigned a Buy rating on Viatris (VTRS – Research Report), with a price target ...

Viatris Inc.'s volatile stock performance, CEO's strategic focus on growth, and promising pipeline highlight potential for ...

Today's Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Netflix, Inc. (NFLX) and ...

Vinyl Group CEO Josh Simons holds vast ambitions for his growing ASX-listed music-technology company. He wants to connect a thousand of the leading brands in the world with 100 million creators and a ...

West Pharmaceutical Services Inc ( NYSE:WST) showcases robust net income despite market challenges. Comprehensive income ...

Analysts dive into balance sheets and income statements to estimate ... medical test taking was going to be permanent. Meanwhile, generic drugmaker Perrigo’s newer CEO is making better capital ...